PMID: 9539780May 16, 1998Paper

Chimeric anti-angiogenin antibody cAb 26-2F inhibits the formation of human breast cancer xenografts in athymic mice

Proceedings of the National Academy of Sciences of the United States of America
R PiccoliJames W Fett

Abstract

Angiogenin (Ang), an inducer of neovascularization, is secreted by several types of human tumor cells and appears critical for their growth. The murine anti-Ang monoclonal antibody (mAb) 26-2F neutralizes the activities of Ang and dramatically prevents the establishment and metastatic dissemination of human tumor cell xenografts in athymic mice. However, for use clinically, the well-documented problem of the human anti-globulin antibody response known to occur with murine antibodies requires resolution. As a result, chimeric as well as totally humanized antibodies are currently being evaluated as therapeutic agents for the treatment of several pathological conditions, including malignancy. Therefore, we have constructed a chimeric mouse/human antibody based on the structure of mAb 26-2F. Complementary DNAs from the light and heavy chain variable regions of mAb 26-2F were cloned, sequenced, and genetically engineered by PCR for subcloning into expression vectors that contain human constant region sequences. Transfection of these vectors into nonproducing mouse myeloma cells resulted in the secretion of fully assembled tetrameric molecules. The chimeric antibody (cAb 26-2F) binds to Ang and inhibits its ribonucleolytic and angiog...Continue Reading

References

Jan 3, 1990·Journal of the National Cancer Institute·J Folkman
Jun 1, 1990·Biochimica Et Biophysica Acta·C H Blood, B R Zetter
Feb 1, 1990·Cancer·C J Logothetis
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A F LoBuglioM B Khazaeli
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S C Hartman, R C Mulligan
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R ShapiroB L Vallee
Aug 23, 1988·Biochemistry·K KurachiB L Vallee
Aug 14, 1987·Biochemical and Biophysical Research Communications·S M RybakB L Vallee
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S L MorrisonV T Oi
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R C Mulligan, P Berg
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·K A OlsonB L Vallee
Jan 1, 1994·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·M B KhazaeliA F LoBuglio
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·K R AcharyaB L Vallee
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·G F HuB L Vallee

❮ Previous
Next ❯

Citations

Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Karen A OlsonJames W Fett
May 9, 2000·Critical Reviews in Oncology/hematology·M Hagedorn, A Bikfalvi
May 23, 2001·Drug Discovery Today·D J. HicklinP Bohlen
Jul 20, 2001·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·J Matousek
Mar 29, 2002·Molecular Biology and Evolution·Jianzhi Zhang, Helene F Rosenberg
Oct 19, 2010·BMC Evolutionary Biology·Francisco M CodoñerMario A Fares
Sep 22, 2007·BMC Evolutionary Biology·Daniel S OsorioMaria J Ramos
Jul 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Richard Y T KaoRobert Shapiro
Mar 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Shentong FangPetri Salven
May 9, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yang YuanSheng-dong Huang
Mar 2, 2005·Biochemical and Biophysical Research Communications·Huajun HuZhengping Xu
Mar 28, 2006·Biochemical and Biophysical Research Communications·Mi-Ran YounSoo-Ik Chang
Sep 15, 2016·Biomolecular NMR Assignments·Aikaterini C TsikaGeorgios A Spyroulias
May 10, 2008·Acta Biochimica Et Biophysica Sinica·Hui ZhangZhengping Xu
Jul 8, 2008·Acta Biochimica Et Biophysica Sinica·Xiangwei Gao, Zhengping Xu
May 27, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ulrika W NilssonCharlotta Dabrosin
Feb 3, 2021·International Journal of Molecular Sciences·Mayuresh Anant Sarangdhar, Ramanjaneyulu Allam
May 21, 1999·Biochemical and Biophysical Research Communications·S J VerselisJ W Fett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Karen A OlsonB L Vallee
Proceedings of the National Academy of Sciences of the United States of America
G F HuB L Vallee
Cellular and Molecular Life Sciences : CMLS
D J Strydom
© 2022 Meta ULC. All rights reserved